An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-11-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetic (PK) exposures of a single subcutaneous (SC) dose of tozorakimab administered using AI or APFS in healthy participants.